Schering-Plough Corp. has announced plans to adopt a new global model for its clinical trial operations, designed to maximize its product portfolio through centralized global processes and functional units that are “efficient, compliant and customer-focused.” This model is expected to enhance how the company plans and manages the progression of therapeutic compounds through clinical trials toward commercialization. Under the Global Clinical Harmonization (GCH) program, all clini...